| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Telomere | 77 | 2024 | 931 | 8.850 |
Why?
|
| Endometrial Neoplasms | 65 | 2024 | 1357 | 8.510 |
Why?
|
| Leukocytes | 51 | 2024 | 2025 | 4.700 |
Why?
|
| Genetic Predisposition to Disease | 80 | 2023 | 17768 | 1.840 |
Why?
|
| Polymorphism, Genetic | 34 | 2015 | 4284 | 1.780 |
Why?
|
| Polymorphism, Single Nucleotide | 77 | 2024 | 15773 | 1.560 |
Why?
|
| Genome-Wide Association Study | 48 | 2024 | 12604 | 1.400 |
Why?
|
| Case-Control Studies | 107 | 2024 | 22029 | 1.330 |
Why?
|
| Telomerase | 10 | 2023 | 745 | 1.270 |
Why?
|
| DNA, Mitochondrial | 11 | 2023 | 856 | 1.160 |
Why?
|
| Aging | 26 | 2024 | 8650 | 1.070 |
Why?
|
| Receptors, Progesterone | 6 | 2017 | 1130 | 1.010 |
Why?
|
| Nurses | 19 | 2017 | 2467 | 0.940 |
Why?
|
| Urinary Bladder Neoplasms | 16 | 2023 | 2276 | 0.870 |
Why?
|
| DNA Copy Number Variations | 11 | 2023 | 2012 | 0.830 |
Why?
|
| Genotype | 53 | 2024 | 12945 | 0.820 |
Why?
|
| Adenocarcinoma | 10 | 2016 | 6313 | 0.800 |
Why?
|
| Body Mass Index | 26 | 2023 | 12876 | 0.780 |
Why?
|
| Risk Factors | 112 | 2024 | 73809 | 0.750 |
Why?
|
| Middle Aged | 175 | 2024 | 219568 | 0.750 |
Why?
|
| Glutathione Transferase | 5 | 2011 | 564 | 0.720 |
Why?
|
| Female | 234 | 2024 | 390323 | 0.720 |
Why?
|
| Ovarian Neoplasms | 16 | 2023 | 4876 | 0.710 |
Why?
|
| Glucuronosyltransferase | 5 | 2012 | 130 | 0.680 |
Why?
|
| Alleles | 30 | 2021 | 6895 | 0.680 |
Why?
|
| Carbon | 2 | 2013 | 667 | 0.660 |
Why?
|
| Estradiol | 9 | 2012 | 1933 | 0.640 |
Why?
|
| DNA Methylation | 15 | 2024 | 4373 | 0.640 |
Why?
|
| Humans | 293 | 2024 | 758406 | 0.610 |
Why?
|
| Genetic Loci | 10 | 2017 | 2612 | 0.600 |
Why?
|
| Coffee | 3 | 2020 | 582 | 0.590 |
Why?
|
| Arylamine N-Acetyltransferase | 4 | 2023 | 86 | 0.580 |
Why?
|
| Genetic Variation | 18 | 2021 | 6548 | 0.580 |
Why?
|
| Adult | 141 | 2024 | 219935 | 0.580 |
Why?
|
| Postmenopause | 8 | 2012 | 2509 | 0.560 |
Why?
|
| Vitamin D | 4 | 2015 | 3283 | 0.550 |
Why?
|
| Diet | 14 | 2023 | 8005 | 0.550 |
Why?
|
| Smoking | 24 | 2017 | 9051 | 0.550 |
Why?
|
| Aromatase | 6 | 2009 | 147 | 0.510 |
Why?
|
| Prospective Studies | 69 | 2023 | 54137 | 0.510 |
Why?
|
| Paternal Age | 2 | 2012 | 87 | 0.510 |
Why?
|
| Diet, Mediterranean | 3 | 2020 | 736 | 0.510 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2008 | 367 | 0.490 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 5 | 2008 | 244 | 0.490 |
Why?
|
| Haplotypes | 12 | 2014 | 2764 | 0.460 |
Why?
|
| Aged | 98 | 2024 | 168218 | 0.460 |
Why?
|
| Gene Frequency | 13 | 2024 | 3612 | 0.440 |
Why?
|
| Skin Neoplasms | 13 | 2020 | 5797 | 0.440 |
Why?
|
| Metabolic Networks and Pathways | 3 | 2017 | 786 | 0.430 |
Why?
|
| Phobic Disorders | 3 | 2018 | 437 | 0.430 |
Why?
|
| Sex Hormone-Binding Globulin | 2 | 2012 | 546 | 0.420 |
Why?
|
| Talc | 2 | 2010 | 48 | 0.420 |
Why?
|
| Carcinoma, Basal Cell | 6 | 2016 | 559 | 0.410 |
Why?
|
| Breast Neoplasms | 22 | 2015 | 21017 | 0.400 |
Why?
|
| Menarche | 3 | 2024 | 529 | 0.400 |
Why?
|
| Catechol O-Methyltransferase | 2 | 2004 | 251 | 0.400 |
Why?
|
| Caffeine | 5 | 2020 | 701 | 0.390 |
Why?
|
| Risk | 19 | 2024 | 9599 | 0.380 |
Why?
|
| Social Class | 4 | 2023 | 1999 | 0.380 |
Why?
|
| Estradiol Dehydrogenases | 1 | 2010 | 15 | 0.380 |
Why?
|
| Endometriosis | 4 | 2023 | 874 | 0.380 |
Why?
|
| Cohort Studies | 47 | 2024 | 41256 | 0.370 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 1 | 2010 | 54 | 0.370 |
Why?
|
| Arthritis, Rheumatoid | 6 | 2016 | 3755 | 0.370 |
Why?
|
| Hydro-Lyases | 1 | 2010 | 93 | 0.370 |
Why?
|
| Life Change Events | 3 | 2024 | 953 | 0.360 |
Why?
|
| Vitamin B Complex | 1 | 2013 | 297 | 0.360 |
Why?
|
| Cross-Sectional Studies | 24 | 2024 | 25956 | 0.360 |
Why?
|
| Estrone | 6 | 2010 | 232 | 0.360 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 1 | 1 | 2011 | 125 | 0.360 |
Why?
|
| Cholesterol Side-Chain Cleavage Enzyme | 1 | 2010 | 27 | 0.360 |
Why?
|
| Menopause | 9 | 2024 | 1639 | 0.350 |
Why?
|
| Polymerase Chain Reaction | 15 | 2016 | 6068 | 0.350 |
Why?
|
| Puberty | 3 | 2024 | 498 | 0.340 |
Why?
|
| Body Height | 3 | 2023 | 1567 | 0.340 |
Why?
|
| Obesity | 14 | 2023 | 12870 | 0.330 |
Why?
|
| Reproduction | 3 | 2015 | 646 | 0.330 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2011 | 268 | 0.330 |
Why?
|
| Life Style | 8 | 2021 | 3886 | 0.330 |
Why?
|
| Epigenesis, Genetic | 8 | 2024 | 3754 | 0.320 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2011 | 415 | 0.320 |
Why?
|
| Leiomyoma | 3 | 2010 | 654 | 0.320 |
Why?
|
| Temperament | 2 | 2023 | 295 | 0.320 |
Why?
|
| Perineum | 1 | 2010 | 208 | 0.320 |
Why?
|
| Estrogen Replacement Therapy | 4 | 2010 | 1206 | 0.320 |
Why?
|
| Antioxidants | 5 | 2021 | 1662 | 0.320 |
Why?
|
| Hyperinsulinism | 2 | 2023 | 400 | 0.320 |
Why?
|
| Logistic Models | 23 | 2023 | 13276 | 0.310 |
Why?
|
| Receptors, Estrogen | 1 | 2017 | 2210 | 0.310 |
Why?
|
| Neoplasms | 12 | 2023 | 22032 | 0.310 |
Why?
|
| Carotenoids | 4 | 2007 | 620 | 0.300 |
Why?
|
| Uterine Neoplasms | 4 | 2013 | 1439 | 0.300 |
Why?
|
| Melanoma | 7 | 2020 | 5691 | 0.290 |
Why?
|
| Male | 104 | 2024 | 358747 | 0.290 |
Why?
|
| Maternal Exposure | 3 | 2019 | 1045 | 0.290 |
Why?
|
| Pancreatic Neoplasms | 7 | 2021 | 5349 | 0.290 |
Why?
|
| DNA | 8 | 2022 | 7199 | 0.280 |
Why?
|
| Epigenomics | 3 | 2024 | 936 | 0.280 |
Why?
|
| Gene Dosage | 4 | 2016 | 1218 | 0.280 |
Why?
|
| Exercise | 3 | 2020 | 5788 | 0.280 |
Why?
|
| Nutritional Status | 3 | 2018 | 1607 | 0.270 |
Why?
|
| Nevus | 2 | 2020 | 205 | 0.270 |
Why?
|
| Isoenzymes | 3 | 2006 | 1686 | 0.270 |
Why?
|
| Receptors, Androgen | 4 | 2009 | 1077 | 0.270 |
Why?
|
| Epidemiologic Methods | 1 | 2011 | 1338 | 0.270 |
Why?
|
| Diet Records | 4 | 2016 | 427 | 0.270 |
Why?
|
| GATA5 Transcription Factor | 1 | 2006 | 18 | 0.270 |
Why?
|
| O(6)-Methylguanine-DNA Methyltransferase | 1 | 2006 | 83 | 0.270 |
Why?
|
| Vitamin B 12 | 2 | 2023 | 522 | 0.270 |
Why?
|
| Oxidative Stress | 10 | 2023 | 3099 | 0.260 |
Why?
|
| Mitochondria | 5 | 2023 | 3584 | 0.260 |
Why?
|
| Models, Genetic | 6 | 2020 | 3441 | 0.250 |
Why?
|
| Genes, p53 | 3 | 2007 | 712 | 0.250 |
Why?
|
| Research Design | 3 | 2022 | 6157 | 0.250 |
Why?
|
| Women's Health | 8 | 2019 | 2057 | 0.250 |
Why?
|
| Odds Ratio | 17 | 2016 | 9650 | 0.250 |
Why?
|
| Incidence | 15 | 2024 | 21272 | 0.240 |
Why?
|
| Multifactorial Inheritance | 4 | 2024 | 1365 | 0.240 |
Why?
|
| Contraceptives, Oral, Hormonal | 1 | 2005 | 190 | 0.230 |
Why?
|
| Longevity | 3 | 2021 | 1050 | 0.230 |
Why?
|
| Stress Disorders, Post-Traumatic | 7 | 2018 | 4560 | 0.230 |
Why?
|
| Hydroxysteroid Dehydrogenases | 1 | 2004 | 29 | 0.230 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2007 | 2872 | 0.230 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 2004 | 763 | 0.230 |
Why?
|
| Androgens | 2 | 2009 | 1291 | 0.230 |
Why?
|
| Amino Acid Substitution | 3 | 2004 | 1734 | 0.230 |
Why?
|
| Dietary Supplements | 3 | 2023 | 3387 | 0.230 |
Why?
|
| Insulin Resistance | 1 | 2018 | 3941 | 0.220 |
Why?
|
| United States | 40 | 2024 | 72136 | 0.220 |
Why?
|
| Lymphoma, Non-Hodgkin | 2 | 2022 | 1373 | 0.220 |
Why?
|
| Phenol | 1 | 2023 | 44 | 0.220 |
Why?
|
| Testosterone | 2 | 2012 | 2471 | 0.220 |
Why?
|
| Genetic Association Studies | 6 | 2016 | 2717 | 0.220 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2022 | 1373 | 0.220 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2011 | 1927 | 0.210 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2004 | 275 | 0.210 |
Why?
|
| Sequence Analysis, DNA | 5 | 2018 | 4711 | 0.210 |
Why?
|
| Depression | 7 | 2020 | 8057 | 0.210 |
Why?
|
| Proportional Hazards Models | 9 | 2020 | 12440 | 0.210 |
Why?
|
| Petroleum | 1 | 2022 | 80 | 0.210 |
Why?
|
| Mosaicism | 2 | 2016 | 465 | 0.200 |
Why?
|
| Confidence Intervals | 7 | 2013 | 2925 | 0.200 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 3 | 2019 | 1651 | 0.200 |
Why?
|
| Follow-Up Studies | 22 | 2023 | 39059 | 0.200 |
Why?
|
| Steroid 17-alpha-Hydroxylase | 2 | 2003 | 99 | 0.200 |
Why?
|
| DNA Damage | 4 | 2021 | 2439 | 0.200 |
Why?
|
| Mendelian Randomization Analysis | 3 | 2022 | 993 | 0.200 |
Why?
|
| Phenols | 2 | 2023 | 514 | 0.200 |
Why?
|
| Germ-Line Mutation | 3 | 2017 | 1840 | 0.200 |
Why?
|
| PPAR gamma | 1 | 2004 | 482 | 0.200 |
Why?
|
| Age Factors | 15 | 2021 | 18358 | 0.190 |
Why?
|
| Environment | 2 | 2023 | 1118 | 0.190 |
Why?
|
| Least-Squares Analysis | 2 | 2012 | 369 | 0.190 |
Why?
|
| Diet Surveys | 2 | 2016 | 1161 | 0.190 |
Why?
|
| Gonadal Steroid Hormones | 2 | 2017 | 701 | 0.180 |
Why?
|
| Phosphoproteins | 1 | 2010 | 2433 | 0.180 |
Why?
|
| Myelodysplastic Syndromes | 2 | 2021 | 1392 | 0.180 |
Why?
|
| Anxiety Disorders | 1 | 2012 | 2714 | 0.180 |
Why?
|
| Insulin | 2 | 2020 | 6578 | 0.180 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2003 | 328 | 0.180 |
Why?
|
| Barrett Esophagus | 2 | 2019 | 490 | 0.180 |
Why?
|
| Risk Assessment | 14 | 2020 | 23884 | 0.180 |
Why?
|
| Chromosomes, Human, Pair 18 | 2 | 2011 | 246 | 0.180 |
Why?
|
| DNA Repair | 5 | 2021 | 2038 | 0.180 |
Why?
|
| Apolipoprotein E4 | 2 | 2024 | 706 | 0.180 |
Why?
|
| Urogenital Neoplasms | 1 | 2021 | 135 | 0.180 |
Why?
|
| Cognition | 4 | 2024 | 6953 | 0.170 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2002 | 411 | 0.170 |
Why?
|
| Osteosarcoma | 2 | 2023 | 897 | 0.170 |
Why?
|
| Mutation, Missense | 3 | 2009 | 2564 | 0.170 |
Why?
|
| Triclosan | 1 | 2019 | 58 | 0.170 |
Why?
|
| Longitudinal Studies | 14 | 2023 | 14490 | 0.160 |
Why?
|
| Membrane Proteins | 6 | 2023 | 7843 | 0.160 |
Why?
|
| Occupational Diseases | 4 | 2014 | 1486 | 0.160 |
Why?
|
| Cholecalciferol | 1 | 2024 | 549 | 0.160 |
Why?
|
| Ovary | 2 | 2021 | 958 | 0.160 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 2000 | 412 | 0.160 |
Why?
|
| Occupational Exposure | 3 | 2021 | 1809 | 0.160 |
Why?
|
| Linkage Disequilibrium | 9 | 2016 | 1996 | 0.160 |
Why?
|
| Astronauts | 1 | 2019 | 92 | 0.150 |
Why?
|
| Siblings | 2 | 2020 | 824 | 0.150 |
Why?
|
| Flavonols | 1 | 2018 | 83 | 0.150 |
Why?
|
| Vinyl Chloride | 2 | 1996 | 15 | 0.150 |
Why?
|
| Cholesterol, HDL | 3 | 2022 | 1808 | 0.150 |
Why?
|
| Inflammation | 8 | 2023 | 10718 | 0.150 |
Why?
|
| Receptors, Adiponectin | 1 | 2018 | 81 | 0.150 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2018 | 8506 | 0.150 |
Why?
|
| DNA-Binding Proteins | 8 | 2014 | 9574 | 0.150 |
Why?
|
| Folic Acid | 4 | 2013 | 1309 | 0.150 |
Why?
|
| Colorectal Neoplasms | 4 | 2022 | 6852 | 0.150 |
Why?
|
| Mammals | 1 | 2023 | 1132 | 0.150 |
Why?
|
| Aged, 80 and over | 19 | 2024 | 58683 | 0.150 |
Why?
|
| Cacao | 1 | 2018 | 98 | 0.150 |
Why?
|
| Cell Survival | 2 | 2023 | 5781 | 0.140 |
Why?
|
| Particulate Matter | 4 | 2018 | 2556 | 0.140 |
Why?
|
| Estrogens | 4 | 2015 | 1520 | 0.140 |
Why?
|
| Prognosis | 14 | 2020 | 29557 | 0.140 |
Why?
|
| Cooking | 2 | 2022 | 311 | 0.140 |
Why?
|
| Ribonucleoproteins | 2 | 2017 | 372 | 0.140 |
Why?
|
| Smoke | 1 | 2019 | 236 | 0.140 |
Why?
|
| Stress, Psychological | 4 | 2024 | 4455 | 0.140 |
Why?
|
| Health Surveys | 6 | 2020 | 4064 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 22 | 2 | 2010 | 346 | 0.140 |
Why?
|
| Arachidonic Acid | 1 | 2018 | 427 | 0.140 |
Why?
|
| Apoptosis | 4 | 2009 | 9468 | 0.140 |
Why?
|
| Life Expectancy | 1 | 2023 | 1244 | 0.140 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 2016 | 68 | 0.140 |
Why?
|
| Endocrine Disruptors | 1 | 2019 | 263 | 0.140 |
Why?
|
| Residence Characteristics | 3 | 2023 | 2058 | 0.130 |
Why?
|
| Space Flight | 1 | 2019 | 214 | 0.130 |
Why?
|
| Receptors, Leptin | 1 | 2018 | 350 | 0.130 |
Why?
|
| Thioredoxin Reductase 2 | 1 | 2016 | 25 | 0.130 |
Why?
|
| Retinoid X Receptor alpha | 1 | 2015 | 16 | 0.130 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2000 | 586 | 0.130 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2022 | 3216 | 0.130 |
Why?
|
| DNA, Neoplasm | 5 | 2012 | 1745 | 0.130 |
Why?
|
| Alcohol Drinking | 4 | 2020 | 4018 | 0.130 |
Why?
|
| Disease-Free Survival | 4 | 2021 | 6821 | 0.130 |
Why?
|
| Anesthetics, Inhalation | 1 | 2021 | 574 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2016 | 127 | 0.130 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2000 | 1055 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2021 | 12075 | 0.130 |
Why?
|
| Fertilization in Vitro | 1 | 2003 | 1292 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 5 | 2 | 2014 | 385 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2016 | 193 | 0.130 |
Why?
|
| Population Groups | 1 | 2016 | 211 | 0.130 |
Why?
|
| ROC Curve | 1 | 2023 | 3563 | 0.120 |
Why?
|
| Homocysteine | 1 | 2018 | 638 | 0.120 |
Why?
|
| Birth Weight | 1 | 2023 | 2097 | 0.120 |
Why?
|
| Air Pollution, Indoor | 1 | 2022 | 893 | 0.120 |
Why?
|
| Gene Expression Profiling | 3 | 2016 | 9404 | 0.120 |
Why?
|
| Depressive Disorder, Major | 4 | 2018 | 4745 | 0.120 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2016 | 373 | 0.120 |
Why?
|
| Phthalic Acids | 1 | 2019 | 477 | 0.120 |
Why?
|
| Estrogen Receptor alpha | 2 | 2017 | 580 | 0.120 |
Why?
|
| Carcinogens | 2 | 2012 | 451 | 0.120 |
Why?
|
| Memory | 1 | 2024 | 2179 | 0.120 |
Why?
|
| Estrogen Receptor beta | 1 | 2015 | 168 | 0.120 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2018 | 560 | 0.120 |
Why?
|
| Phenotype | 9 | 2020 | 16534 | 0.120 |
Why?
|
| Cholesterol, LDL | 2 | 2022 | 2374 | 0.120 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2014 | 48 | 0.120 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2011 | 1134 | 0.120 |
Why?
|
| Pilot Projects | 5 | 2023 | 8553 | 0.120 |
Why?
|
| Menstrual Cycle | 2 | 2015 | 536 | 0.120 |
Why?
|
| Genome, Human | 3 | 2015 | 4416 | 0.120 |
Why?
|
| Chromosomes, Human, X | 1 | 2016 | 321 | 0.120 |
Why?
|
| Cyclin E | 1 | 2014 | 155 | 0.120 |
Why?
|
| Vesicular Monoamine Transport Proteins | 1 | 2014 | 32 | 0.110 |
Why?
|
| Caregivers | 2 | 2018 | 2225 | 0.110 |
Why?
|
| Carcinoma, Squamous Cell | 4 | 2016 | 4023 | 0.110 |
Why?
|
| Tumor Burden | 1 | 2020 | 1893 | 0.110 |
Why?
|
| X Chromosome Inactivation | 1 | 2016 | 226 | 0.110 |
Why?
|
| Apolipoproteins E | 3 | 2024 | 1436 | 0.110 |
Why?
|
| MicroRNAs | 2 | 2022 | 3783 | 0.110 |
Why?
|
| Receptor, Insulin | 1 | 2018 | 833 | 0.110 |
Why?
|
| Transplantation Conditioning | 1 | 2020 | 1588 | 0.110 |
Why?
|
| Body Fat Distribution | 1 | 2015 | 243 | 0.110 |
Why?
|
| Triglycerides | 2 | 2020 | 2451 | 0.110 |
Why?
|
| Work Schedule Tolerance | 2 | 2023 | 551 | 0.110 |
Why?
|
| Casein Kinase II | 1 | 2014 | 122 | 0.110 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2022 | 909 | 0.110 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 15225 | 0.110 |
Why?
|
| Saliva | 2 | 2015 | 820 | 0.110 |
Why?
|
| Genes, ras | 3 | 2008 | 654 | 0.110 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2013 | 92 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2014 | 347 | 0.110 |
Why?
|
| Gallstones | 1 | 2016 | 283 | 0.110 |
Why?
|
| Health Behavior | 2 | 2016 | 2617 | 0.110 |
Why?
|
| Dementia | 1 | 2008 | 2650 | 0.110 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2020 | 1826 | 0.110 |
Why?
|
| Europe | 6 | 2021 | 3420 | 0.110 |
Why?
|
| Welding | 1 | 2014 | 89 | 0.110 |
Why?
|
| Intrauterine Devices | 1 | 2014 | 114 | 0.110 |
Why?
|
| Antigens, CD | 2 | 2018 | 3997 | 0.110 |
Why?
|
| Epidemiologic Studies | 4 | 2018 | 670 | 0.110 |
Why?
|
| Adolescent | 19 | 2024 | 87892 | 0.110 |
Why?
|
| Mutagens | 1 | 2014 | 178 | 0.110 |
Why?
|
| Polycyclic Compounds | 1 | 1992 | 29 | 0.110 |
Why?
|
| Mixed Tumor, Mullerian | 1 | 2013 | 55 | 0.110 |
Why?
|
| Love | 1 | 2013 | 39 | 0.110 |
Why?
|
| Anemia, Aplastic | 1 | 2015 | 228 | 0.110 |
Why?
|
| Intestinal Polyps | 1 | 1993 | 104 | 0.110 |
Why?
|
| Hemangiosarcoma | 2 | 1996 | 216 | 0.100 |
Why?
|
| Genetic Markers | 4 | 2023 | 2608 | 0.100 |
Why?
|
| Critical Pathways | 1 | 2016 | 473 | 0.100 |
Why?
|
| Carcinogens, Environmental | 1 | 1992 | 72 | 0.100 |
Why?
|
| Cause of Death | 3 | 2020 | 3675 | 0.100 |
Why?
|
| Child Abuse, Sexual | 1 | 2015 | 394 | 0.100 |
Why?
|
| Adaptation, Physiological | 1 | 2019 | 1295 | 0.100 |
Why?
|
| Child Development | 2 | 2023 | 2285 | 0.100 |
Why?
|
| Genomic Instability | 2 | 2019 | 704 | 0.100 |
Why?
|
| Disabled Children | 1 | 2014 | 251 | 0.100 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2013 | 131 | 0.100 |
Why?
|
| Stem Cell Transplantation | 1 | 2020 | 1599 | 0.100 |
Why?
|
| Nepal | 2 | 2023 | 301 | 0.100 |
Why?
|
| Alzheimer Disease | 2 | 2024 | 8544 | 0.100 |
Why?
|
| Adiponectin | 1 | 2018 | 1114 | 0.100 |
Why?
|
| Genomic Imprinting | 3 | 2017 | 330 | 0.100 |
Why?
|
| Vitamin B 6 | 1 | 2013 | 233 | 0.100 |
Why?
|
| Cell Division | 2 | 1998 | 4458 | 0.100 |
Why?
|
| Interleukin-12 Subunit p35 | 1 | 2011 | 21 | 0.100 |
Why?
|
| Spinal Cord Injuries | 1 | 2019 | 924 | 0.100 |
Why?
|
| Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I | 1 | 2011 | 52 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2014 | 4485 | 0.100 |
Why?
|
| Occupations | 1 | 2014 | 515 | 0.100 |
Why?
|
| Sex Factors | 4 | 2020 | 10504 | 0.090 |
Why?
|
| Socioeconomic Factors | 6 | 2024 | 7818 | 0.090 |
Why?
|
| Cell Proliferation | 2 | 2023 | 10416 | 0.090 |
Why?
|
| Prostatic Neoplasms | 4 | 2023 | 11336 | 0.090 |
Why?
|
| Chromosome Aberrations | 2 | 2015 | 1763 | 0.090 |
Why?
|
| Infant, Premature | 1 | 2021 | 2092 | 0.090 |
Why?
|
| Premenopause | 3 | 2008 | 1038 | 0.090 |
Why?
|
| Depressive Disorder | 3 | 2019 | 3727 | 0.090 |
Why?
|
| Neoplasm Proteins | 2 | 2014 | 3609 | 0.090 |
Why?
|
| Choline | 1 | 2013 | 513 | 0.090 |
Why?
|
| Inhalation Exposure | 1 | 2014 | 429 | 0.090 |
Why?
|
| Neoplasms, Basal Cell | 1 | 2010 | 31 | 0.090 |
Why?
|
| Leukocyte Count | 1 | 2014 | 1593 | 0.090 |
Why?
|
| Receptors, Calcitriol | 1 | 2013 | 359 | 0.090 |
Why?
|
| Psychosocial Deprivation | 1 | 2011 | 99 | 0.090 |
Why?
|
| Methionine | 1 | 2013 | 569 | 0.090 |
Why?
|
| Oncogene Proteins | 1 | 2014 | 719 | 0.090 |
Why?
|
| Receptor, Melanocortin, Type 4 | 1 | 2011 | 128 | 0.090 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2010 | 95 | 0.090 |
Why?
|
| Carcinoma, Endometrioid | 1 | 2013 | 276 | 0.090 |
Why?
|
| Neoplasm Invasiveness | 4 | 2015 | 3617 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2013 | 698 | 0.090 |
Why?
|
| Environmental Pollutants | 1 | 2019 | 1268 | 0.090 |
Why?
|
| Hypothalamus | 1 | 2015 | 998 | 0.090 |
Why?
|
| Gene Expression | 2 | 2021 | 7583 | 0.090 |
Why?
|
| Child, Institutionalized | 1 | 2011 | 106 | 0.090 |
Why?
|
| Meditation | 1 | 2013 | 251 | 0.090 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2000 | 2800 | 0.090 |
Why?
|
| Cognition Disorders | 3 | 2011 | 3975 | 0.090 |
Why?
|
| Anesthesia | 1 | 2021 | 1582 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2010 | 313 | 0.080 |
Why?
|
| Probability | 2 | 2021 | 2467 | 0.080 |
Why?
|
| Quantitative Trait Loci | 4 | 2020 | 2100 | 0.080 |
Why?
|
| Maternal Age | 1 | 2012 | 807 | 0.080 |
Why?
|
| Reference Values | 3 | 2007 | 4919 | 0.080 |
Why?
|
| Lymphoma, B-Cell | 1 | 2016 | 935 | 0.080 |
Why?
|
| Linear Models | 3 | 2017 | 5862 | 0.080 |
Why?
|
| Lung Neoplasms | 8 | 2020 | 13245 | 0.080 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2016 | 734 | 0.080 |
Why?
|
| BRCA1 Protein | 1 | 2015 | 1147 | 0.080 |
Why?
|
| Nails | 2 | 2014 | 295 | 0.080 |
Why?
|
| Resilience, Psychological | 1 | 2016 | 772 | 0.080 |
Why?
|
| Breast Feeding | 1 | 2017 | 1355 | 0.080 |
Why?
|
| Kv1.5 Potassium Channel | 1 | 2008 | 5 | 0.080 |
Why?
|
| Young Adult | 14 | 2023 | 58808 | 0.080 |
Why?
|
| Parturition | 1 | 2012 | 446 | 0.080 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2009 | 358 | 0.080 |
Why?
|
| Codon | 2 | 2004 | 602 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 1611 | 0.080 |
Why?
|
| Rhodopsin | 1 | 2009 | 203 | 0.080 |
Why?
|
| Infant | 9 | 2023 | 36055 | 0.080 |
Why?
|
| Anthropometry | 2 | 2016 | 1347 | 0.080 |
Why?
|
| Reproducibility of Results | 5 | 2022 | 20055 | 0.080 |
Why?
|
| Carrier Proteins | 2 | 1998 | 4938 | 0.080 |
Why?
|
| Perception | 1 | 2014 | 1197 | 0.080 |
Why?
|
| Child | 14 | 2024 | 79818 | 0.080 |
Why?
|
| HLA-DR Antigens | 1 | 2010 | 630 | 0.080 |
Why?
|
| Adiposity | 1 | 2018 | 1858 | 0.080 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | 2008 | 64 | 0.080 |
Why?
|
| Hormones | 2 | 2003 | 869 | 0.080 |
Why?
|
| Colonic Polyps | 1 | 1993 | 551 | 0.080 |
Why?
|
| Calcium | 2 | 2013 | 5721 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 2009 | 534 | 0.070 |
Why?
|
| Hydrolases | 1 | 2008 | 146 | 0.070 |
Why?
|
| Parents | 3 | 2020 | 3548 | 0.070 |
Why?
|
| Base Sequence | 4 | 2009 | 12436 | 0.070 |
Why?
|
| Cell Growth Processes | 1 | 2008 | 384 | 0.070 |
Why?
|
| Disease Susceptibility | 2 | 2004 | 1788 | 0.070 |
Why?
|
| Carcinoma in Situ | 1 | 2013 | 796 | 0.070 |
Why?
|
| Autoimmune Diseases | 1 | 2019 | 2244 | 0.070 |
Why?
|
| Prolactin | 1 | 2009 | 621 | 0.070 |
Why?
|
| Metabolomics | 1 | 2016 | 1629 | 0.070 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2008 | 293 | 0.070 |
Why?
|
| Neoplasm Staging | 5 | 2013 | 11152 | 0.070 |
Why?
|
| Ethanol | 1 | 2013 | 1323 | 0.070 |
Why?
|
| Promoter Regions, Genetic | 4 | 2006 | 5779 | 0.070 |
Why?
|
| Venous Thromboembolism | 2 | 2017 | 1855 | 0.070 |
Why?
|
| Alanine | 2 | 2009 | 603 | 0.070 |
Why?
|
| Environmental Exposure | 2 | 2019 | 4412 | 0.070 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 1994 | 1725 | 0.070 |
Why?
|
| CpG Islands | 2 | 2022 | 1221 | 0.070 |
Why?
|
| NFATC Transcription Factors | 1 | 2008 | 381 | 0.070 |
Why?
|
| Child, Preschool | 8 | 2023 | 42062 | 0.070 |
Why?
|
| Membrane Transport Proteins | 1 | 2011 | 1034 | 0.060 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2008 | 714 | 0.060 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2014 | 3384 | 0.060 |
Why?
|
| Regression Analysis | 3 | 2014 | 6354 | 0.060 |
Why?
|
| Sex Characteristics | 4 | 2024 | 2621 | 0.060 |
Why?
|
| Retinitis Pigmentosa | 1 | 2009 | 397 | 0.060 |
Why?
|
| Tissue Donors | 1 | 2015 | 2311 | 0.060 |
Why?
|
| Self Report | 2 | 2018 | 3714 | 0.060 |
Why?
|
| B-Lymphocytes | 1 | 1998 | 4738 | 0.060 |
Why?
|
| Animals | 12 | 2024 | 167768 | 0.060 |
Why?
|
| Meta-Analysis as Topic | 3 | 2014 | 1373 | 0.060 |
Why?
|
| Androstenedione | 1 | 2004 | 131 | 0.060 |
Why?
|
| Body Size | 1 | 2007 | 462 | 0.060 |
Why?
|
| Stromal Cells | 1 | 2010 | 1326 | 0.060 |
Why?
|
| Air Pollution | 1 | 2018 | 2314 | 0.060 |
Why?
|
| Neuroendocrine Tumors | 1 | 2011 | 650 | 0.060 |
Why?
|
| Survival Rate | 4 | 2021 | 12721 | 0.060 |
Why?
|
| Flavonoids | 1 | 2007 | 443 | 0.060 |
Why?
|
| Air Pollutants | 1 | 2018 | 2842 | 0.060 |
Why?
|
| Hematologic Neoplasms | 1 | 2016 | 1890 | 0.060 |
Why?
|
| Estrogens, Catechol | 1 | 2004 | 25 | 0.060 |
Why?
|
| Glucuronides | 1 | 2004 | 20 | 0.060 |
Why?
|
| Trinucleotide Repeats | 1 | 2005 | 257 | 0.060 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2008 | 487 | 0.060 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2006 | 296 | 0.060 |
Why?
|
| Hypertension | 1 | 2024 | 8499 | 0.060 |
Why?
|
| Rectal Neoplasms | 1 | 1993 | 1152 | 0.060 |
Why?
|
| Proteins | 3 | 2014 | 6026 | 0.060 |
Why?
|
| Ketone Bodies | 1 | 2023 | 76 | 0.060 |
Why?
|
| Lung | 3 | 2022 | 9985 | 0.060 |
Why?
|
| Puberty, Delayed | 1 | 2024 | 121 | 0.060 |
Why?
|
| Genomics | 2 | 2016 | 5790 | 0.050 |
Why?
|
| RNA | 1 | 2013 | 2716 | 0.050 |
Why?
|
| Anxiety | 1 | 2018 | 4539 | 0.050 |
Why?
|
| Pregnancy | 7 | 2020 | 29742 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2019 | 10146 | 0.050 |
Why?
|
| Leucine | 1 | 2004 | 547 | 0.050 |
Why?
|
| Acetaminophen | 1 | 2007 | 552 | 0.050 |
Why?
|
| Hypertriglyceridemia | 1 | 2006 | 293 | 0.050 |
Why?
|
| Mutation | 6 | 2017 | 29915 | 0.050 |
Why?
|
| Neuropsychological Tests | 3 | 2024 | 7021 | 0.050 |
Why?
|
| Puberty, Precocious | 1 | 2024 | 163 | 0.050 |
Why?
|
| Valine | 1 | 2004 | 408 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2011 | 2825 | 0.050 |
Why?
|
| Organ Size | 1 | 2008 | 2252 | 0.050 |
Why?
|
| Selenium | 1 | 2005 | 416 | 0.050 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2023 | 118 | 0.050 |
Why?
|
| Double-Blind Method | 2 | 2023 | 12262 | 0.050 |
Why?
|
| Health Resources | 1 | 2009 | 931 | 0.050 |
Why?
|
| Infant, Newborn | 5 | 2021 | 26183 | 0.050 |
Why?
|
| Poland | 2 | 2012 | 196 | 0.050 |
Why?
|
| Australia | 3 | 2012 | 1276 | 0.050 |
Why?
|
| Codon, Terminator | 1 | 2002 | 125 | 0.050 |
Why?
|
| Adenoma | 1 | 1993 | 2148 | 0.050 |
Why?
|
| beta Carotene | 1 | 2003 | 523 | 0.050 |
Why?
|
| Cell Line, Tumor | 3 | 2008 | 16886 | 0.050 |
Why?
|
| Cardiovascular Diseases | 4 | 2017 | 15399 | 0.050 |
Why?
|
| Fertility | 2 | 2021 | 773 | 0.050 |
Why?
|
| Sleep | 2 | 2023 | 4744 | 0.050 |
Why?
|
| Massachusetts | 5 | 2015 | 8823 | 0.050 |
Why?
|
| Educational Status | 2 | 2024 | 2513 | 0.050 |
Why?
|
| Motor Activity | 1 | 2012 | 2685 | 0.050 |
Why?
|
| Liver Neoplasms | 2 | 1996 | 4313 | 0.050 |
Why?
|
| Age Distribution | 1 | 2007 | 2882 | 0.050 |
Why?
|
| Embryo Implantation | 1 | 2003 | 270 | 0.050 |
Why?
|
| Sarcoma | 1 | 2013 | 1785 | 0.050 |
Why?
|
| Personality Inventory | 1 | 2004 | 1018 | 0.050 |
Why?
|
| Ultraviolet Rays | 2 | 2016 | 1076 | 0.050 |
Why?
|
| Fatty Acids, Omega-6 | 1 | 2022 | 226 | 0.050 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 2850 | 0.050 |
Why?
|
| Multivariate Analysis | 2 | 2013 | 12096 | 0.050 |
Why?
|
| Endometrium | 1 | 2004 | 403 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 4567 | 0.050 |
Why?
|
| Epithelial Cells | 2 | 2010 | 3664 | 0.050 |
Why?
|
| Calcium-Binding Proteins | 2 | 2017 | 1066 | 0.050 |
Why?
|
| Primary Ovarian Insufficiency | 1 | 2021 | 105 | 0.050 |
Why?
|
| Survival Analysis | 3 | 2020 | 10112 | 0.050 |
Why?
|
| Hospitalization | 1 | 2021 | 10652 | 0.050 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2021 | 116 | 0.050 |
Why?
|
| Fetal Blood | 2 | 2018 | 1343 | 0.050 |
Why?
|
| Endophenotypes | 1 | 2022 | 255 | 0.050 |
Why?
|
| Mouth Mucosa | 1 | 2003 | 426 | 0.040 |
Why?
|
| Vitamin D Deficiency | 1 | 2010 | 1377 | 0.040 |
Why?
|
| Molecular Sequence Data | 5 | 2009 | 17617 | 0.040 |
Why?
|
| China | 3 | 2012 | 2333 | 0.040 |
Why?
|
| Nitrous Oxide | 1 | 2021 | 166 | 0.040 |
Why?
|
| Menopause, Premature | 1 | 2021 | 124 | 0.040 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2000 | 330 | 0.040 |
Why?
|
| Signal Transduction | 4 | 2018 | 23342 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2014 | 3992 | 0.040 |
Why?
|
| Population Surveillance | 1 | 2010 | 2606 | 0.040 |
Why?
|
| Epidemiologic Research Design | 1 | 2003 | 368 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2004 | 1792 | 0.040 |
Why?
|
| Social Justice | 1 | 2024 | 479 | 0.040 |
Why?
|
| Chi-Square Distribution | 3 | 2014 | 3425 | 0.040 |
Why?
|
| United States National Aeronautics and Space Administration | 1 | 2019 | 15 | 0.040 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2022 | 3774 | 0.040 |
Why?
|
| Brain Ischemia | 1 | 2013 | 3047 | 0.040 |
Why?
|
| Wheelchairs | 1 | 2019 | 78 | 0.040 |
Why?
|
| Vitamins | 2 | 2005 | 1632 | 0.040 |
Why?
|
| Melphalan | 1 | 2020 | 420 | 0.040 |
Why?
|
| Binding Sites | 2 | 2006 | 6036 | 0.040 |
Why?
|
| Mental Disorders | 1 | 2019 | 6803 | 0.040 |
Why?
|
| Nitrosamines | 1 | 2019 | 87 | 0.040 |
Why?
|
| Flavanones | 1 | 2019 | 73 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 855 | 0.040 |
Why?
|
| Nutrition Surveys | 2 | 2020 | 1716 | 0.040 |
Why?
|
| Glioma | 1 | 2013 | 3418 | 0.040 |
Why?
|
| Germ Cells | 1 | 2022 | 635 | 0.040 |
Why?
|
| Growth Disorders | 1 | 2023 | 653 | 0.040 |
Why?
|
| Urinary Bladder Diseases | 1 | 2019 | 169 | 0.040 |
Why?
|
| Catechin | 1 | 2018 | 69 | 0.040 |
Why?
|
| Oxidants | 1 | 2019 | 169 | 0.040 |
Why?
|
| Women | 1 | 2020 | 225 | 0.040 |
Why?
|
| Air Pollutants, Occupational | 1 | 2021 | 407 | 0.040 |
Why?
|
| Group VI Phospholipases A2 | 1 | 2017 | 16 | 0.040 |
Why?
|
| Fruit | 2 | 2019 | 1160 | 0.040 |
Why?
|
| Vegetables | 2 | 2019 | 1195 | 0.040 |
Why?
|
| Chromosome Mapping | 3 | 2012 | 4624 | 0.040 |
Why?
|
| South Africa | 1 | 2023 | 1821 | 0.040 |
Why?
|
| Spain | 2 | 2010 | 488 | 0.040 |
Why?
|
| Microsatellite Repeats | 1 | 2000 | 785 | 0.040 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2023 | 1074 | 0.040 |
Why?
|
| Ketones | 1 | 2019 | 183 | 0.040 |
Why?
|
| Placenta | 2 | 2017 | 1702 | 0.040 |
Why?
|
| Bone Neoplasms | 2 | 2023 | 2531 | 0.040 |
Why?
|
| Caloric Restriction | 1 | 2020 | 296 | 0.040 |
Why?
|
| Isoflurane | 1 | 2021 | 384 | 0.040 |
Why?
|
| Uterus | 1 | 2021 | 651 | 0.040 |
Why?
|
| Colonic Neoplasms | 1 | 2009 | 2523 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2008 | 10748 | 0.040 |
Why?
|
| Fasting | 1 | 2023 | 1599 | 0.040 |
Why?
|
| Chronic Disease | 3 | 2019 | 9267 | 0.040 |
Why?
|
| Dopamine | 1 | 2004 | 1599 | 0.040 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2007 | 2269 | 0.040 |
Why?
|
| New Hampshire | 2 | 2008 | 173 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2005 | 2322 | 0.030 |
Why?
|
| Urinary Bladder | 2 | 2014 | 1166 | 0.030 |
Why?
|
| Cotinine | 1 | 2017 | 203 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2024 | 1245 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2015 | 5649 | 0.030 |
Why?
|
| Personality Assessment | 1 | 2018 | 650 | 0.030 |
Why?
|
| Heterozygote | 3 | 2009 | 2797 | 0.030 |
Why?
|
| SEER Program | 1 | 2021 | 1530 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2017 | 1887 | 0.030 |
Why?
|
| Registries | 3 | 2023 | 8175 | 0.030 |
Why?
|
| Genetic Drift | 1 | 2016 | 41 | 0.030 |
Why?
|
| Death Certificates | 1 | 2016 | 167 | 0.030 |
Why?
|
| Cytochrome P-450 CYP1A1 | 2 | 2008 | 90 | 0.030 |
Why?
|
| Molecular Epidemiology | 2 | 1996 | 469 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 1998 | 459 | 0.030 |
Why?
|
| Psychology | 1 | 2018 | 356 | 0.030 |
Why?
|
| Retroviridae | 1 | 1998 | 850 | 0.030 |
Why?
|
| Dietary Fats | 1 | 2003 | 1991 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2002 | 2359 | 0.030 |
Why?
|
| Interleukin-1beta | 2 | 2014 | 996 | 0.030 |
Why?
|
| Mice | 6 | 2024 | 81101 | 0.030 |
Why?
|
| Causality | 1 | 2022 | 1241 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 1998 | 896 | 0.030 |
Why?
|
| Mobility Limitation | 1 | 2019 | 400 | 0.030 |
Why?
|
| Aspirin | 1 | 2007 | 3131 | 0.030 |
Why?
|
| Hippocampus | 1 | 2008 | 3736 | 0.030 |
Why?
|
| Health Occupations | 1 | 2016 | 222 | 0.030 |
Why?
|
| Prejudice | 1 | 2019 | 571 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2022 | 1803 | 0.030 |
Why?
|
| Feeding Behavior | 2 | 2019 | 3184 | 0.030 |
Why?
|
| Carotid Arteries | 1 | 2019 | 939 | 0.030 |
Why?
|
| Karyotyping | 1 | 2016 | 1171 | 0.030 |
Why?
|
| Receptors, GABA-B | 1 | 2014 | 58 | 0.030 |
Why?
|
| Protein Isoforms | 2 | 2012 | 1694 | 0.030 |
Why?
|
| Epistasis, Genetic | 1 | 2016 | 350 | 0.030 |
Why?
|
| Exercise Tolerance | 1 | 2019 | 830 | 0.030 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2000 | 1113 | 0.030 |
Why?
|
| Homozygote | 2 | 2009 | 1788 | 0.030 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2014 | 57 | 0.030 |
Why?
|
| Exons | 1 | 2000 | 2387 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2019 | 726 | 0.030 |
Why?
|
| Labor Unions | 1 | 2014 | 49 | 0.030 |
Why?
|
| Chile | 1 | 2014 | 255 | 0.030 |
Why?
|
| Waist-Hip Ratio | 1 | 2015 | 516 | 0.030 |
Why?
|
| Nicotine | 1 | 2019 | 677 | 0.030 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2021 | 833 | 0.030 |
Why?
|
| HLA Antigens | 1 | 2019 | 1368 | 0.030 |
Why?
|
| Tissue Array Analysis | 1 | 2015 | 551 | 0.030 |
Why?
|
| Prefrontal Cortex | 1 | 2004 | 2209 | 0.030 |
Why?
|
| Prevalence | 3 | 2017 | 15651 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2013 | 14641 | 0.030 |
Why?
|
| Parkinson Disease | 1 | 2008 | 2862 | 0.030 |
Why?
|
| Receptors, Retinoic Acid | 1 | 2014 | 224 | 0.030 |
Why?
|
| Alu Elements | 1 | 2014 | 115 | 0.030 |
Why?
|
| Data Collection | 1 | 2023 | 3322 | 0.030 |
Why?
|
| Protein Binding | 3 | 2006 | 9311 | 0.030 |
Why?
|
| Air | 1 | 2014 | 186 | 0.030 |
Why?
|
| Carcinoma | 1 | 2004 | 2330 | 0.030 |
Why?
|
| Weight Gain | 1 | 2023 | 2346 | 0.030 |
Why?
|
| Sister Chromatid Exchange | 1 | 1992 | 60 | 0.030 |
Why?
|
| Pigmentation | 1 | 2013 | 144 | 0.030 |
Why?
|
| Genetic Pleiotropy | 1 | 2014 | 181 | 0.030 |
Why?
|
| Glutathione S-Transferase pi | 2 | 2003 | 100 | 0.030 |
Why?
|
| Michigan | 1 | 2013 | 341 | 0.030 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 1994 | 2912 | 0.030 |
Why?
|
| Phylogeny | 1 | 2000 | 2774 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2023 | 2895 | 0.030 |
Why?
|
| Metals, Heavy | 1 | 2014 | 150 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2000 | 6127 | 0.030 |
Why?
|
| Algorithms | 2 | 2020 | 13961 | 0.030 |
Why?
|
| Oncogene Proteins, Viral | 1 | 1994 | 341 | 0.030 |
Why?
|
| Cholesterol | 2 | 2016 | 2902 | 0.020 |
Why?
|
| tau Proteins | 1 | 2022 | 2085 | 0.020 |
Why?
|
| Long Interspersed Nucleotide Elements | 1 | 2014 | 330 | 0.020 |
Why?
|
| Marital Status | 1 | 2013 | 432 | 0.020 |
Why?
|
| Dioxygenases | 1 | 2014 | 332 | 0.020 |
Why?
|
| Weight Loss | 1 | 2023 | 2671 | 0.020 |
Why?
|
| Time Factors | 4 | 2019 | 39872 | 0.020 |
Why?
|
| Sunlight | 1 | 2013 | 337 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2005 | 6201 | 0.020 |
Why?
|
| Waist Circumference | 1 | 2015 | 921 | 0.020 |
Why?
|
| Overweight | 1 | 2022 | 2411 | 0.020 |
Why?
|
| Telomeric Repeat Binding Protein 1 | 1 | 2010 | 7 | 0.020 |
Why?
|
| Hair Color | 1 | 2011 | 131 | 0.020 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2008 | 5246 | 0.020 |
Why?
|
| Contraception | 1 | 2014 | 349 | 0.020 |
Why?
|
| Interleukin-8 | 1 | 2014 | 696 | 0.020 |
Why?
|
| Contraceptives, Oral | 1 | 2013 | 554 | 0.020 |
Why?
|
| Religion | 1 | 2014 | 376 | 0.020 |
Why?
|
| Bone and Bones | 1 | 2021 | 2560 | 0.020 |
Why?
|
| Risk Reduction Behavior | 1 | 2017 | 1098 | 0.020 |
Why?
|
| Stroke | 1 | 2013 | 9694 | 0.020 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2014 | 699 | 0.020 |
Why?
|
| Foster Home Care | 1 | 2011 | 134 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2017 | 1737 | 0.020 |
Why?
|
| Pedigree | 1 | 2017 | 4578 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2020 | 2907 | 0.020 |
Why?
|
| Selection Bias | 1 | 2011 | 357 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 1998 | 6209 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2022 | 3533 | 0.020 |
Why?
|
| Testicular Neoplasms | 1 | 2015 | 801 | 0.020 |
Why?
|
| Amyloid beta-Peptides | 1 | 2022 | 3826 | 0.020 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2009 | 56 | 0.020 |
Why?
|
| Parity | 1 | 2012 | 925 | 0.020 |
Why?
|
| Finland | 1 | 2010 | 603 | 0.020 |
Why?
|
| Cytochrome P-450 CYP1A2 | 1 | 2008 | 69 | 0.020 |
Why?
|
| Genetic Heterogeneity | 1 | 2012 | 723 | 0.020 |
Why?
|
| Transcription Factors | 3 | 2003 | 12094 | 0.020 |
Why?
|
| Gestational Age | 1 | 2017 | 3565 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2016 | 2001 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2014 | 1174 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2014 | 3096 | 0.020 |
Why?
|
| Comorbidity | 1 | 2023 | 10495 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 1994 | 989 | 0.020 |
Why?
|
| Inheritance Patterns | 1 | 2010 | 340 | 0.020 |
Why?
|
| Body Weight | 1 | 2019 | 4603 | 0.020 |
Why?
|
| Microdissection | 1 | 2008 | 151 | 0.020 |
Why?
|
| Camptothecin | 1 | 2012 | 588 | 0.020 |
Why?
|
| Sample Size | 1 | 2011 | 838 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2013 | 1630 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2010 | 956 | 0.020 |
Why?
|
| Fas Ligand Protein | 1 | 2008 | 215 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2010 | 783 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2011 | 1570 | 0.020 |
Why?
|
| Pain | 1 | 2023 | 5065 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2013 | 11070 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2021 | 3433 | 0.020 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2009 | 211 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2016 | 1895 | 0.020 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2009 | 296 | 0.020 |
Why?
|
| India | 1 | 2014 | 2329 | 0.020 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2009 | 203 | 0.020 |
Why?
|
| Hospitals | 1 | 2021 | 3887 | 0.020 |
Why?
|
| Liver | 2 | 2012 | 7502 | 0.020 |
Why?
|
| Lipids | 1 | 2018 | 3326 | 0.020 |
Why?
|
| Precancerous Conditions | 1 | 1994 | 977 | 0.020 |
Why?
|
| Electroretinography | 1 | 2009 | 517 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 2014 | 1888 | 0.020 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2010 | 540 | 0.020 |
Why?
|
| Gene Regulatory Networks | 1 | 2015 | 1740 | 0.020 |
Why?
|
| Seasons | 1 | 1992 | 1519 | 0.020 |
Why?
|
| Chromatin | 1 | 2018 | 2938 | 0.020 |
Why?
|
| Retrospective Studies | 4 | 2010 | 80168 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 2009 | 862 | 0.020 |
Why?
|
| Glycine | 1 | 2009 | 662 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2015 | 4809 | 0.020 |
Why?
|
| Environmental Monitoring | 1 | 1992 | 1445 | 0.020 |
Why?
|
| Pancreatic Ducts | 1 | 2008 | 329 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2006 | 130 | 0.020 |
Why?
|
| Public Health Nursing | 1 | 2005 | 14 | 0.020 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2015 | 1402 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2014 | 6234 | 0.020 |
Why?
|
| Models, Statistical | 2 | 2015 | 5070 | 0.020 |
Why?
|
| Veterans | 1 | 2018 | 2631 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2008 | 2013 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2015 | 6493 | 0.010 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2015 | 1627 | 0.010 |
Why?
|
| Fats, Unsaturated | 1 | 2003 | 21 | 0.010 |
Why?
|
| Lasers | 1 | 2008 | 952 | 0.010 |
Why?
|
| Adaptation, Psychological | 1 | 2014 | 2629 | 0.010 |
Why?
|
| Interleukin-6 | 1 | 2014 | 3208 | 0.010 |
Why?
|
| DNA Ligases | 1 | 2003 | 82 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 2009 | 1133 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 2009 | 1436 | 0.010 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2003 | 46 | 0.010 |
Why?
|
| Epitopes | 1 | 2010 | 2502 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2008 | 2626 | 0.010 |
Why?
|
| Data Interpretation, Statistical | 1 | 2013 | 2690 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 22003 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2014 | 8297 | 0.010 |
Why?
|
| Violence | 1 | 2009 | 934 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2014 | 3480 | 0.010 |
Why?
|
| Rad52 DNA Repair and Recombination Protein | 1 | 2002 | 28 | 0.010 |
Why?
|
| Verbal Learning | 1 | 2005 | 462 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 1998 | 18940 | 0.010 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 2942 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 1994 | 3801 | 0.010 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2014 | 4342 | 0.010 |
Why?
|
| International Cooperation | 1 | 2009 | 1430 | 0.010 |
Why?
|
| Computational Biology | 1 | 2014 | 3502 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2014 | 3812 | 0.010 |
Why?
|
| Proline | 1 | 2003 | 456 | 0.010 |
Why?
|
| TATA Box | 1 | 2001 | 127 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 15785 | 0.010 |
Why?
|
| Body Composition | 1 | 2010 | 2416 | 0.010 |
Why?
|
| Methyltransferases | 1 | 2003 | 374 | 0.010 |
Why?
|
| Family | 1 | 2010 | 3188 | 0.010 |
Why?
|
| Transcription, Genetic | 2 | 2006 | 7590 | 0.010 |
Why?
|
| Disease Progression | 1 | 2016 | 13468 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2022 | 20500 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2009 | 6013 | 0.010 |
Why?
|
| Kidney Neoplasms | 1 | 2015 | 4312 | 0.010 |
Why?
|
| Memory, Short-Term | 1 | 2005 | 978 | 0.010 |
Why?
|
| Healthcare Disparities | 1 | 2014 | 3364 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 1998 | 68 | 0.010 |
Why?
|
| Quality of Life | 1 | 2019 | 13285 | 0.010 |
Why?
|
| Histone Chaperones | 1 | 1998 | 82 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2013 | 7980 | 0.010 |
Why?
|
| Brain | 1 | 2024 | 26947 | 0.010 |
Why?
|
| Introns | 1 | 2000 | 978 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2024 | 36284 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2003 | 64378 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2012 | 12759 | 0.010 |
Why?
|
| Internet | 1 | 2009 | 3082 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1998 | 1084 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2001 | 1752 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 2011 | 4402 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2013 | 5816 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 1998 | 1165 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1992 | 11892 | 0.010 |
Why?
|
| France | 1 | 1996 | 499 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2006 | 3299 | 0.010 |
Why?
|
| Silicosis | 1 | 1994 | 47 | 0.010 |
Why?
|
| Asbestosis | 1 | 1994 | 81 | 0.010 |
Why?
|
| Receptors, Growth Factor | 1 | 1995 | 326 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 1998 | 13447 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1998 | 2753 | 0.010 |
Why?
|
| Health Personnel | 1 | 2007 | 3312 | 0.010 |
Why?
|
| Receptor, erbB-2 | 2 | 1994 | 2553 | 0.010 |
Why?
|
| Mass Screening | 1 | 2009 | 5427 | 0.010 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 1998 | 727 | 0.010 |
Why?
|
| Growth Substances | 1 | 1995 | 768 | 0.010 |
Why?
|
| Asbestos | 1 | 1994 | 251 | 0.010 |
Why?
|
| Mammography | 1 | 2003 | 2427 | 0.010 |
Why?
|
| Carcinoma, Small Cell | 1 | 1994 | 416 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 1998 | 3796 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1994 | 1647 | 0.010 |
Why?
|
| GTP-Binding Proteins | 1 | 1995 | 950 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 1992 | 1229 | 0.010 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 1994 | 1096 | 0.000 |
Why?
|
| Lymphatic Metastasis | 1 | 1994 | 2943 | 0.000 |
Why?
|
| Myocardium | 1 | 1998 | 4690 | 0.000 |
Why?
|
| Protein Conformation | 1 | 1992 | 3966 | 0.000 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1996 | 2292 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1998 | 11471 | 0.000 |
Why?
|
| Peptides | 1 | 1992 | 4341 | 0.000 |
Why?
|